Md. Negligence Doctrine Gives Takeda Win In Actos Suit

Md. Negligence Doctrine Gives Takeda Win In Actos Suit

Takeda Pharmaceuticals USA Inc. on Thursday dodged a potential $1.8 million jury award in a suit over its diabetes drug Actos because the Maryland jury also found that the plaintiff had contributed to his death from bladder cancer, which bars damages ...read more

  • Tags: